Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · Dental EconomicsGroup Dentistry NowDental PracticesSuccession Planning
Share
Learn this in 60 seconds

Key facts, context, and what it means, in one minute.

:60
0:001:00
Dental practice exits are turning into multi-year projects, not last-year decisions

Key takeaways

01

A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.

02

If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.

03

Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

According to Dental Economics, dentists should outline a succession plan before they need one. That approach turns an exit into planned work, including clarity on a potential sale price and deal structure, and involving tax, legal, and financial professionals to prepare agreements as needed.

Dental Economics has been consistent on the point across multiple 2024 pieces: succession and sale planning is something that belongs on the calendar well ahead of a retirement date, because the mechanics take time and the consequences are hard to reverse once documents are signed.

Three years is the floor for many succession paths

In an April 2024 column, Mark Kravietz of Aline Wealth outlined a timeline operators can realistically use for planning. Dental Economics reported that if succession means hiring an associate with the expectation that the associate will purchase the practice, the transition typically lasts at least three years and often extends beyond five.

That timeline matters because it moves several “later” decisions into the present. Hiring an associate is no longer purely a capacity decision. It becomes a governance decision (what authority is delegated and when), a reporting decision (what metrics show readiness), and a continuity decision (what patients and staff experience during the handoff).

In dentistry, the sale is the event. The transition is the project.

The deal structure starts as an accounting and tax problem

The March 2024 Dental Economics retirement-planning guidance from Natalie Haggard and Andrew Loving is blunt about sequencing: engage tax, legal, and financial professionals early enough to draft buy-sell agreements and model sale outcomes before you commit to a path. Their warning is operational as much as financial, wait until after the sale and many options to minimize taxes are already off the table, according to Dental Economics.

They also frame valuation as a planning input, not a closing number. If an owner is five to 10 years from selling, Dental Economics recommends engaging a wealth team to understand what the practice is worth and how to improve value before any buyer is identified. For multi-location groups, that turns valuation into a discipline: consistent coding and posting, stable scheduling capacity, and a revenue cycle that can withstand turnover.

Kravietz describes using a practice valuation as the basis for “what-if” scenarios in a broader plan, stress-testing what happens if a seller gets less than hoped. That approach, as reported by Dental Economics, is a reminder that purchase price is not a strategy. It is an assumption that should be interrogated.

Large-practice management is pushing exits upstream

Scale changes what breaks first. Group Dentistry Now’s large-practice management guidance argues that as organizations get bigger, errors get bigger too, and the ability to delegate depends on having defined, tracked systems that let leaders spot red flags early.

Its most actionable example lands in the revenue cycle, especially for DSOs and multi-office operators: a claims aging report that looks scary can be “falsely inflated” because of basic accounting and posting gaps, Group Dentistry Now reports. In other words, what looks like payer delay can also be a workflow defect: payments not posted, adjustments not recorded, or claims not reconciled. In a transition, those issues turn into diligence questions and working-capital surprises.

Group Dentistry Now also flags common owner pain points as operational constraints: employee management, insurance reimbursement friction, and patient collections. It ties insurance-related drag to longer phone waits and slower communications as payer staff moved remote, which it says can delay responses and claims payment processing. Whatever the cause in a given market, the operator implication is the same: exits are easier when the revenue cycle is measurable, repeatable, and resilient to staffing churn.

A clean A/R report is an exit asset. A messy one becomes a buyer’s spreadsheet problem.

Training discipline is the quiet prerequisite to standardizing care and cash flow

One of the easiest mistakes in a practice transition is treating clinical capability as “already handled” while focusing on the business package. But the skill-transfer lesson from outside dentistry is relevant. Ophthalmology Times reported in 2023 that new ocular injection devices are often not intuitive and require both instruction and hands-on experience, with a mix of in-person and live virtual training and the support of local product representatives.

For dental groups, the parallel is straightforward: when adding new tools, new workflows, or even new managers during an ownership change, training needs to be designed, scheduled, and retrained on demand. Consistency is what protects outcomes and also stabilizes production. The practice that can prove it trains, verifies, and refreshes technique across providers is often the same practice that can prove it posts, reconciles, and follows up on claims the same way across locations.

Where this lands in 2026 planning for owners and DSOs

  • For owners considering an associate-led succession, map the 3-year minimum timeline into hiring, credentialing, and delegation plans, then define what “ready to buy” means in metrics and responsibilities, using the Dental Economics benchmark as the planning floor.
  • Before engaging buyers or brokers, run an internal revenue-cycle audit focused on A/R integrity: posting discipline, adjustment rules, and claim reconciliation. Group Dentistry Now’s “falsely inflated aging” example is a useful diagnostic starting point.
  • Put tax structure and transition support into the same workstream as valuation. Dental Economics’ guidance is clear that waiting until after a sale can remove tax-structuring options, and transition terms can affect both patient continuity and financial outcomes.
  • If the practice is standardizing tools or adding locations, treat training like an operational control, not an HR task. Ophthalmology Times’ mix of in-person, virtual, and kit-based practice is a model for how to roll out technique changes without variability creeping into care and production.

Featured companies

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512